BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22830334)

  • 1. Derivatives of resveratrol: potential agents in prevention and treatment of cardiovascular disease.
    Ruan BF; Lu XQ; Song J; Zhu HL
    Curr Med Chem; 2012; 19(24):4175-83. PubMed ID: 22830334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Versatility of Resveratrol Derivatives.
    Nawaz W; Zhou Z; Deng S; Ma X; Ma X; Li C; Shu X
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29109374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol: biologic and therapeutic implications.
    Sadruddin S; Arora R
    J Cardiometab Syndr; 2009; 4(2):102-6. PubMed ID: 19614797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol and derivatives for the prevention and treatment of cancer.
    Fulda S
    Drug Discov Today; 2010 Sep; 15(17-18):757-65. PubMed ID: 20692359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol in cardiovascular disease: what is known from current research?
    Wang H; Yang YJ; Qian HY; Zhang Q; Xu H; Li JJ
    Heart Fail Rev; 2012 May; 17(3):437-48. PubMed ID: 21688187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects and molecular targets of resveratrol.
    Li H; Xia N; Förstermann U
    Nitric Oxide; 2012 Feb; 26(2):102-10. PubMed ID: 22245452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol induces Sirt1-dependent apoptosis in 3T3-L1 preadipocytes by activating AMPK and suppressing AKT activity and survivin expression.
    Chen S; Xiao X; Feng X; Li W; Zhou N; Zheng L; Sun Y; Zhang Z; Zhu W
    J Nutr Biochem; 2012 Sep; 23(9):1100-12. PubMed ID: 22137261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From resveratrol to its derivatives: new sources of natural antioxidant.
    He S; Yan X
    Curr Med Chem; 2013; 20(8):1005-17. PubMed ID: 23210785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological effects of resveratrol.
    Frémont L
    Life Sci; 2000 Jan; 66(8):663-73. PubMed ID: 10680575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol.
    Fullerton MD; Steinberg GR
    Diabetes; 2010 Mar; 59(3):551-3. PubMed ID: 20190133
    [No Abstract]   [Full Text] [Related]  

  • 11. Resveratrol oligomers for the prevention and treatment of cancers.
    Xue YQ; Di JM; Luo Y; Cheng KJ; Wei X; Shi Z
    Oxid Med Cell Longev; 2014; 2014():765832. PubMed ID: 24799982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol in peanuts.
    Sales JM; Resurreccion AV
    Crit Rev Food Sci Nutr; 2014; 54(6):734-70. PubMed ID: 24345046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The basis for the chemopreventive action of resveratrol.
    Roemer K; Mahyar-Roemer M
    Drugs Today (Barc); 2002 Aug; 38(8):571-80. PubMed ID: 12582422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of resveratrol on damages of mouse cortical neurons induced by β-amyloid through activation of SIRT1/Akt1 pathway.
    Zhang J; Feng X; Wu J; Xu H; Li G; Zhu D; Yue Q; Liu H; Zhang Y; Sun D; Wang H; Sun J
    Biofactors; 2014; 40(2):258-67. PubMed ID: 24132831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway.
    Kanamori H; Takemura G; Goto K; Tsujimoto A; Ogino A; Takeyama T; Kawaguchi T; Watanabe T; Morishita K; Kawasaki M; Mikami A; Fujiwara T; Fujiwara H; Seishima M; Minatoguchi S
    Am J Pathol; 2013 Mar; 182(3):701-13. PubMed ID: 23274061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
    Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM
    Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol: potential as anticancer agent.
    Aluyen JK; Ton QN; Tran T; Yang AE; Gottlieb HB; Bellanger RA
    J Diet Suppl; 2012 Mar; 9(1):45-56. PubMed ID: 22432802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases.
    Zordoky BN; Robertson IM; Dyck JR
    Biochim Biophys Acta; 2015 Jun; 1852(6):1155-77. PubMed ID: 25451966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol up-regulates AMPA receptor expression via AMP-activated protein kinase-mediated protein translation.
    Wang G; Amato S; Gilbert J; Man HY
    Neuropharmacology; 2015 Aug; 95():144-53. PubMed ID: 25791529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation.
    Manna SK; Mukhopadhyay A; Aggarwal BB
    J Immunol; 2000 Jun; 164(12):6509-19. PubMed ID: 10843709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.